StockWatch
·
Biotechnology: Pharmaceutical Preparations
AGM/EGMMay 22, 2026, 04:11 PM

Inventiva to Hold AGM/EGM on June 30, 2026; Reports EUR 207.9M Loss

AI Summary

Inventiva S.A. announced its Ordinary and Extraordinary General Meeting to be held on June 30, 2026, where shareholders will vote on the approval of the 2025 financial statements. The company reported a significant net accounting loss of EUR 207,965,630.56 for the year, which will be allocated to the 'Report à Nouveau' account. The agenda also includes approvals for executive compensation, renewal and appointment of directors, authorization for share buybacks up to 10% of capital, and various delegations for future share capital increases and debt security issuances.

Key Highlights

  • Inventiva's Ordinary and Extraordinary General Meeting is scheduled for June 30, 2026.
  • The company reported a net accounting loss of EUR 207,965,630.56 for the financial year ended December 31, 2025.
  • The loss will be allocated to the 'Report à Nouveau' account, increasing its debit to EUR 583,594,899.42.
  • Shareholders will vote on the final approval of fixed and variable compensation for key executives for FY2025.
  • The Board is authorized to buyback up to 10% of the company's shares, with a maximum unit price of EUR 40.
  • Delegation of authority to increase share capital by up to EUR 2,000,000 nominal value, with or without preemptive rights.
  • Delegation of authority to issue debt securities up to EUR 500,000,000.
  • Two Director mandates are up for renewal, and three new Directors are proposed for appointment.